Clinical trial NCT01981785: Investigation of Immune Disorders and Deficiencies
Official title: Investigation of Molecular, Genetic and Cellular Mechanisms of Human Immune Disorders and Deficiencies
Study type: OBSERVATIONAL
Overall status: UNKNOWN
Conditions: Primary Immune Deficiencies
Autoimmune Diseases
Inflammatory Diseases
Common Variable Immune Deficiencies
Hypogammaglobulinemia
Keywords: Primary immune deficiencies
Autoimmune diseases
Inflammatory diseases
Common variable immune deficiencies
Primary Immunodeficiencies
Immunoglobulin
IgG
IVIG
Recurrent Infections
Lead sponsor: O & O Alpan LLC
Sponsor class: OTHER
First posted: 2013-11-13
Enrollment: 343
Sex: ALL
Minimum age (years): 1
Standard ages: CHILD
ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Observational model: CASE_CONTROL
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Patients with abnormal immune responses or potential PID or immune disorders (allergies, autoimmune diseases) will be enrolled as the study group and patients with no prior immune abnormalities will be enrolled as the control group.

Brief summary: The immune system is an intricate system comprised of specialized cells, proteins, tissues and organs. Proper functioning is critical to the body's ability to defend itself against harmful pathogens. Immunological disorders and deficiencies are defects in the immune system that lead to abnormal immune responses. Abnormal immune responses could be derived from immune deficiencies, dysregulations or hypersensitivities.

The overall goal of this research study is to identify the mechanisms of primary immune deficiencies and immune disorders at the genetic, cellular and molecular level, using novel analytic techniques to be performed on immune cells derived from blood samples. The knowledge gained from the aims of this study could lead to better diagnostics and identify novel targets for therapeutic interventions.

Detailed description: Primary immunodeficiency diseases (PID) represent a class of disorders in which there is an instrinsic defect in the human immune system. The PID could be caused by defects or perturbations in either the innate or adaptive immune cells, such as B cell defects which result in lack of antibodies. Research in this topic remains a difficult feat due factors such as genetic heterogeneity and the gene-environment interface. Limitations of standard of care testing leads to many patients with immunological problems to be undiagnosed. In addition to the variety of primary immune deficiencies, there are large number of immune system disorders due to various perturbations in the immunological components that cause diseases with much greater prevalence such as autoimmune diseases, lymphoproliferative diseases, chronic inflammation and certain cancers. The causes of these immune disorders are typically more complex than PID but there are also many overlaps in immune hyper-activation and deficiency.

Eligibility criteria: Inclusion Criteria:

* Subject is greater than or equal to 1 day of age and less than or equal to 100years of age
* Signed Informed Consent/Assent
* Subject is able and willing to comply with study protocol requirements
* From clinical or blood laboratory findings subject has evidence of immune abnormalities (or no immune abnormalities in the case of controls) or immune-mediated disease.

Exclusion Criteria:

* Risk factors for donating blood (such as anemia or blood clotting disorders)

Primary outcomes:
measure: Genetic variants
timeFrame: 10 years
Secondary outcomes:
measure: Pathogenesis
timeFrame: 10 years
Other outcomes:
Locations:
city: Fairfax
country: United States
facility: O&O Alpan LLC
state: Virginia
Study officials:
affiliation: O & O Alpan LLC
name: Oral Alpan, MD
role: PRINCIPAL_INVESTIGATOR
References: